EUVIMEDEUVIMED entdecken
Crossref

Neoantigen-based immunotherapy in solid tumors

Chao Chen

China National GeneBank DataBase · 01.01.2024

DOI: 10.26036/cnp0000871 ↗

Kurz gefasst

Fachartikel in der Zeitschrift China National GeneBank DataBase, erschienen am 01.01.2024. Verfasst von Chao Chen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The purpose of this study is to characterize the genomic background of solid tumors and develop neoantigen-based immunotherapy. First, next-generation sequencing was performed on tumor tissues and corresponding peripheral blood of cancer patients. Second, bioinformatics analysis, including HLA typing, mutation detection, identification of tumor-specific antigens (neoantigens) was performed. Then, neoantigen-based cell therapy, such as neoantigen activated cytotoxic T lymphocytes (CTLs), neoantigen-loaded dendritic cells (DCs) were generated for immunotherapy.

Schlagwörter

neoantigenscancer immunotherapysolid tumorstumor-specific antigensHLA typingsomatic mutationscytotoxic T lymphocytesdendritic cell vaccination

Zitieren

APA

Chen, C. (2024). Neoantigen-based immunotherapy in solid tumors. China National GeneBank DataBase. https://doi.org/10.26036/cnp0000871

Vancouver

Chen C. Neoantigen-based immunotherapy in solid tumors. China National GeneBank DataBase. 2024. doi:10.26036/cnp0000871

BibTeX
@article{Chen2024,
  author = {Chen, Chao},
  title = {Neoantigen-based immunotherapy in solid tumors},
  journal = {China National GeneBank DataBase},
  year = {2024},
  doi = {10.26036/cnp0000871}
}
Kostenlos starten →